Opioid dependence treatment, including buprenorphine/naloxone.
about
Evidence-based practices for substance use disordersDrug users' adherence to a 6-month vaccination protocol: effects of motivational incentives.Spiritual Well-Being and Associated Factors with Relapse in Opioid Addicts.Buprenorphine for opioid dependenceHealth-related quality of life changes associated with buprenorphine treatment for opioid dependence.Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis.Brain regulation of food intake and appetite: molecules and networks.Role of buprenorphine in the management of heroin addiction.Quantifying Syringe Exchange Program Operational Space in the District of Columbia.Buprenorphine-naloxone therapy in pain management.Acute pain control challenges with buprenorphine/naloxone therapy in a patient with compartment syndrome secondary to McArdle's disease: a case report and review.The effects of intranasal oxytocin in opioid-dependent individuals and healthy control subjects: a pilot study.Barriers to medical provider support for prescription naloxone as overdose antidote for lay responders.Shifting blame: Buprenorphine prescribers, addiction treatment, and prescription monitoring in middle-class America.Buprenorphine is a weak partial agonist that inhibits opioid receptor desensitization.Experiences of a national sample of qualified addiction specialists who have and have not prescribed buprenorphine for opioid dependence.Development of sensitization to methamphetamine in offspring prenatally exposed to morphine, methadone and buprenorphine.Effects of buprenorphine on cardiac repolarization in a patient with methadone-related torsade de pointes.Association analysis of genes encoding the nociceptin receptor (OPRL1) and its endogenous ligand (PNOC) with alcohol or illicit drug dependence.Buprenorphine treatment: factors and first-hand experiences for providers to consider.
P2860
Q24614016-63C18ACF-3E65-4723-916D-68396FF30B2DQ33625219-4E52A57A-C84D-4010-8C7A-D2ED7858605DQ33666935-E71F9F11-B48E-408B-B7A7-47D1BFE0AF39Q34119459-6AF191B6-D5A9-40B7-931C-2639F3DE26EEQ34129263-1A1539B7-3FE8-4818-9FD9-EAF83B5AEB40Q35892818-EBEB01E7-41E4-4E99-B634-CC9598093472Q36258096-6BBE3BE7-97E8-4CBD-B462-D01F086B6137Q36376715-7ECECE1B-8327-4E19-B807-CA2AB2C297D9Q37413539-863B18EC-8050-4BC5-8CE9-3F4EBBD6E041Q37722356-4B4781A1-71F3-4962-B331-9A7FC3BFD416Q38104462-BC764440-FA9F-41B1-912E-0048BAA3A497Q38393066-1287BD88-4C35-4336-B192-C9FCAA7E20BFQ39424322-3B5E6B8A-FAFC-4EE7-924E-AAA5C94F803DQ40395088-B2C1A71A-1D8D-4BFB-B797-1294335D3A9BQ42566902-DE159D88-97A9-451C-93A5-9F41A88F013EQ44332685-E7F4D32B-8C08-4A52-8943-23105CA977D9Q44392711-7DDC9DD9-1ED8-4A22-BD20-50914C5E32C2Q46565998-190F9F56-30CF-433D-8044-9E4BB2669677Q46970878-74CFDE63-FD3B-45BF-9462-21FEEE2F3B21Q51904834-990F26C2-C01E-42A4-84F5-AEFC146D3030
P2860
Opioid dependence treatment, including buprenorphine/naloxone.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Opioid dependence treatment, including buprenorphine/naloxone.
@ast
Opioid dependence treatment, including buprenorphine/naloxone.
@en
Opioid dependence treatment, including buprenorphine/naloxone.
@nl
type
label
Opioid dependence treatment, including buprenorphine/naloxone.
@ast
Opioid dependence treatment, including buprenorphine/naloxone.
@en
Opioid dependence treatment, including buprenorphine/naloxone.
@nl
prefLabel
Opioid dependence treatment, including buprenorphine/naloxone.
@ast
Opioid dependence treatment, including buprenorphine/naloxone.
@en
Opioid dependence treatment, including buprenorphine/naloxone.
@nl
P2093
P2860
P356
P1476
Opioid dependence treatment, including buprenorphine/naloxone.
@en
P2093
Carol L Fye
Dennis W Raisch
Kathy D Boardman
Mike R Sather
P2860
P304
P356
10.1345/APH.10421
P407
P577
2002-02-01T00:00:00Z